Screener
AMN Healthcare AMN SG&A
SG&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: AMN Healthcare’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054507
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cost of revenue | 467,355 | 461,776 | 1,476,880 | 953,189 |
| Gross profit | 205,882 | 196,399 | 574,718 | 394,519 |
| Operating expenses: | ||||
| Selling, general and administrative | 147,391 | 154,584 | 365,816 | 302,315 |
| Depreciation and amortization (exclusive of depreciation included in cost of revenue) | 31,583 | 37,753 | 64,823 | 75,635 |
| Goodwill impairment loss | — | 109,515 | — | 109,515 |
| Long-lived assets impairment loss | — | 18,262 | — | 18,262 |
| Total operating expenses | 178,974 | 320,114 | 430,639 | 505,727 |
Item 1. Condensed Consolidated Financial Statements
FAQ
- What is AMN Healthcare's SG&A?
- AMN Healthcare (AMN) reported SG&A of $147.39M in Q2 2026.
- How has AMN Healthcare's SG&A changed year-over-year?
- AMN Healthcare's SG&A decreased by 4.7% year-over-year, from $154.58M to $147.39M.
- What is the long-term trend for AMN Healthcare's SG&A?
- Over 4 years (2021 to 2025), AMN Healthcare's SG&A has grown at a -5.1% compound annual growth rate (CAGR), from $730.45M to $593.02M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about AMN Healthcare's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude